ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Multi-Center Examination of the Reliability and Validity of the Live Donor Assessment Tool (LDAT) as an Enhancement to the Psychosocial Evaluation of Living Donors

    D. LaPointe Rudow,1 S. Jowsey-Gregoire,2 F. Desrosiers,3 J. Trompeta,4 LDAT Study Group.1

    1RMTI, Mount Sinai Hosptial, NY, NY; 2Mayo Clinic, Rochester, MN; 3NYPH, NY, NY; 4UCSF, San Francisco, CA.

    Purpose: The LDAT is the first psychosocial assessment tool developed to standardize live donor (LD) psychosocial evaluations (PsychE). It assesses motivation, LD knowledge/expectations, support, closeness…
  • 2018 American Transplant Congress

    Determining the Utility of Protocol Biopsies in Kidney Transplant Recipients

    J. Patel,1 K. Heshmati,2 A. Rogers,1 R. Wali,2 J. Jonsson,2 C. Liu,2 E. Emery,2 D. Collins,2 S. Karzai,2 J. Piper.2

    1Virginia Commonwealth University, Falls Church; 2Inova Fairfax Hospital, Falls Church.

    Protocol biopsies may allow for early detection and treatment of kidney transplant rejection or other correctable pathology, leading to improved graft survival. Unfortunately, biopsies may…
  • 2018 American Transplant Congress

    Comparison of Outcome in Liver Transplant Patients with Renal Insufficiency and Intraoperative CVVH

    J. Gosnell, M. Safwan, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai.

    Transplant Institute, Henry Ford Health System, Detroit, MI.

    Background: Intraoperative continuous veno-venous hemofiltration (CVVH) is an important tool to manage liver transplant (LT) patients with renal insufficiencies. Methods: All LT patients with renal…
  • 2018 American Transplant Congress

    The Safety and Efficacy of Splenic Artery Ligation in Living Donor Liver Transplant Recipients

    Y. Gunay, S. Ganesh, M. Molinari, A. Tevar, C. Hughes, A. Humar.

    Surgery, University of Pittsburgh, Pittsburgh.

    Introduction: Portal hypertension in recipients undergoing living donor liver transplant (LDLT) is thought to be one of the main causes of posttransplant graft dysfunction. In…
  • 2018 American Transplant Congress

    Benefit of Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function

    J. Lee,1 D. Kim,1 J. Lee,2 S. Kim,3 H. Lee,4 S. Song,5 J. Lee,1 M. Ju,1 G. Choi,1 D. Joo,1 J. Choi,1 S. Kim,1 Y. Jung.1

    1Department of Surgery, Yonsei University of College of Medicine, Seoul, Republic of Korea; 2Department of Surgery, CHA Bundang Medical Center, Seongnam, Republic of Korea; 3Department of Surgery, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea; 4Department of Surgery, Ilsan Hospital, Ilsan, Republic of Korea; 5Department of Surgery, Ehwa Wonmen Hospital, Seoul, Republic of Korea.

    Background: To reduce the HBV reinfection after liver transplantation, anti-hepatitis B immunoglobulin (HBIG) alone or combination with antiviral nucleotide analogues are usually used regimen. However,…
  • 2018 American Transplant Congress

    Upper Limb Early Cannulation Arteriovenous Grafts (ecAVG) for Complex Vascular Access – A Healthy Alternative to Central Venous Catheters (CVC)

    M. Khurram,1 I. Mosca,2 F. Calder.3

    1Department of Transplantation, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom; 2Department of Transplantation, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom; 3Department of Transplantation, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

    IntroductionPatients with few transplant options and failing dialysis access are challenging to manage. Transitioning away from a CVC to fistula / graft is often difficult.…
  • 2018 American Transplant Congress

    A Single Center Outcomes Analysis of UNOS Defined "Hard to Place Kidneys"

    Y. Qazi, K. Lee, A. Jones, L. Aguirre, M. Parma, M. Smogorzewski, T. T. Maw, L. Sher.

    Keck Medical Center at USC, Los Angeles, CA.

    The discard rate of potentially usable kidneys remains dismal despite a critical shortage of organs. The Scientific Registry of Transplant Recipients (SRTR) now provides a…
  • 2018 American Transplant Congress

    Laparoscopic Donor Nephrectomy – The BMI Effect

    V. Chia,1 F. Khan,2 M. Newell,2 L. J. Chen.3

    1Surgery, Southmead Hospital, Bristol, England, United Kingdom; 2Clinical Science Institute, National University of Ireland, Galway, Ireland; 3Miami Transplant Institute, University of Miami, Miami.

    Aims: To evaluate the outcomes of Laparoscopic Donor Nephrectomy (LDN) across 4 BMI groups.Methods : Using the SRTR database, all LDNs performed between 2006-2015 were…
  • 2018 American Transplant Congress

    Origin and Traffic of Donor-Derived Extracellular Vesicles during Allo-Sensitization

    F. Zeng,1 W. Shufesky,1 M. Yang,1 Q. Liu,1 A. Larregina,2 A. Morelli.1

    1T.E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA; 2Department of Dermatology, University of Pittsburgh, Pittsburgh, PA.

    The idea that donor dendritic cells (DCs) transplanted with the grafts and mobilized to draining lymphoid tissues (dLTs) present donor MHC molecules to allo-reactive naïve…
  • 2018 American Transplant Congress

    Donor-Derived Cell-Free DNA Identifies Antibody-Mediated Rejection with Graft Injury in DSA-Positive Kidney Transplant Recipients

    S. Jordan,1 S. Bunnapradist,2 J. Bromberg,3 A. Langone,4 D. Hiller,5 J. Yee,5 J. Sninsky,5 R. Woodward,5 A. Matas.6

    1Cedars-Sinai Medical Center, Los Angeles, CA; 2UCLA, Los Angeles, CA; 3University of Maryland School of Medicine, Baltimore, MD; 4Vanerbilt University Medical Center, Nashville, TN; 5CareDx, Brisbane, CA; 6University of Minnesota School of Medicine, Minneapolis, MN.

    Purpose: Donor-derived cell-free DNA (dd-cfDNA) discriminates active rejection in kidney transplant patients. Donor-specific antibodies (DSA) to HLA antigens are associated with risk of antibody-mediated rejection…
  • « Previous Page
  • 1
  • …
  • 155
  • 156
  • 157
  • 158
  • 159
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences